Kang WK - Search Results

1

Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients.

Bray SM, Lee J, Kim ST, Hur JY, Ebert PJ, Calley JN, Wulur IH, Gopalappa T, Wong SS, Qian HR, Ting JC, Liu J, Willard MD, Novosiadly RD, Park YS, Park JO, Lim HY, Kang WK, Aggarwal A, Kim HC, Reinhard C. Bray SM, et al. Among authors: kang wk. Sci Rep. 2019 Oct 25;9(1):15365. doi: 10.1038/s41598-019-51981-5. Sci Rep. 2019. PMID: 31653970 Free PMC article.

2

Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer.

Kim K, Nam E, Lee NS, Lee HR, Lee JY, Lee HR, Park SH, Oh SY, Kim JH, Song SY, Park JO, Kim WS, Jung CW, Im YH, Lee MH, Lee WY, Chun H, Park CH, Park K, Kang WK. Kim K, et al. Among authors: kang wk. Am J Clin Oncol. 2002 Aug;25(4):354-7. doi: 10.1097/00000421-200208000-00007. Am J Clin Oncol. 2002. PMID: 12151964 Clinical Trial.

3

Monensin inhibits the growth of renal cell carcinoma cells via cell cycle arrest or apoptosis.

Park WH, Jung CW, Park JO, Kim K, Kim WS, Im YH, Lee MH, Kang WK, Park K. Park WH, et al. Among authors: kang wk. Int J Oncol. 2003 Apr;22(4):855-60. Int J Oncol. 2003. PMID: 12632079

4

Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis.

Park WH, Jung CW, Park JO, Kim K, Kim WS, Im YH, Lee MH, Kang WK, Park K. Park WH, et al. Among authors: kang wk. Int J Oncol. 2003 May;22(5):1129-34. Int J Oncol. 2003. PMID: 12684681

5

Measuring response in solid tumors: comparison of RECIST and WHO response criteria.

Park JO, Lee SI, Song SY, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Lee KS, Park K. Park JO, et al. Among authors: kang wk. Jpn J Clin Oncol. 2003 Oct;33(10):533-7. doi: 10.1093/jjco/hyg093. Jpn J Clin Oncol. 2003. PMID: 14623923

6

Early concurrent chemoradiotherapy with prolonged oral etoposide and cisplatin for limited-stage small-cell lung cancer.

Lee SH, Ahn YC, Kim HJ, Lim DH, Lee SI, Nam E, Park SH, Park J, Lee KE, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Lee MH, Park K. Lee SH, et al. Among authors: kang wk. Jpn J Clin Oncol. 2003 Dec;33(12):620-5. doi: 10.1093/jjco/hyg115. Jpn J Clin Oncol. 2003. PMID: 14769839 Clinical Trial.

7

The outcomes of hypertransfusion in major ABO incompatible allogeneic stem sell transplantation.

Park SH, Lee MH, Lee SH, Lee KE, Park J, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Park K, Kim SW, Lee KH, Lee JH. Park SH, et al. Among authors: kang wk. J Korean Med Sci. 2004 Feb;19(1):79-82. doi: 10.3346/jkms.2004.19.1.79. J Korean Med Sci. 2004. PMID: 14966346 Free PMC article.

8

Tuberculosis in hematopoietic stem cell transplant recipients in Korea.

Lee J, Lee MH, Kim WS, Kim K, Park SH, Lee SH, Lee KE, Park J, Park JO, Jung CW, Im YH, Kang WK, Park K. Lee J, et al. Among authors: kang wk. Int J Hematol. 2004 Feb;79(2):185-8. doi: 10.1532/ijh97.a10219. Int J Hematol. 2004. PMID: 15005349

9

Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer.

Lee J, Park JO, Kim WS, Lee SI, Song SY, Lim DH, Choi SH, Heo JS, Lee KT, Lee JK, Kim K, Jung CW, Im YH, Lee MH, Kang WK, Park K. Lee J, et al. Among authors: kang wk. Oncology. 2004;66(1):32-7. doi: 10.1159/000076332. Oncology. 2004. PMID: 15031596 Clinical Trial.

10

Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment.

Lee J, Kim WS, Kim K, Ko YH, Kim JJ, Kim YH, Chun HK, Lee WY, Park JO, Jung CW, Im YH, Lee MH, Kang WK, Park K. Lee J, et al. Among authors: kang wk. Leuk Lymphoma. 2004 Feb;45(2):339-44. doi: 10.1080/10428190310001593111. Leuk Lymphoma. 2004. PMID: 15101721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

480 results

Search Page

Filters